Flowshield CF Part B Supersedes Date: New SDS

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

1272/2008 Classification of the substance or mixture

2.2 Label elements

Symbol(s) of Product

Signal word

Danger Named Chemicals on Label 4,4'-Methylenediphenyl diisocyanate, 2,2'-Methylenediphenyl diisocyanate, Diphenylmethane-2,4'-diisocyanate, Isocyanic acid, polymethylenepolyphenylene ester

Hazard statements

Other EU extensions EUH204 Contains isocyanates. May produce an allergic reaction. Skin Irritation, category 2 H315 Causes skin irritation. Skin Sensitizer, category 1 H317 May cause an allergic skin reaction. Eye Irritation, category 2 H319 Causes serious eye irritation. Acute Toxicity, Inhalation, category 4 H332 Harmful if inhaled. Respiratory Sensitizer, category 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. STOT, single exposure, category 3, RTI H335 May cause respiratory irritation. Carcinogenicity, category 2 H351 Suspected of causing cancer. STOT, repeated exposure, category 2 H373 May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/ face protection. P284 Wear respiratory protection. P285 In case of inadequate ventilation wear respiratory protection. P302+352 IF ON SKIN: Wash with plenty of soap and water. P304+340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305+351+338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do so. Continue rinsing. P308+313 IF exposed or concerned: Get medical advice/attention. P314 Get medical advice/attention if you feel unwell. P333+313 If skin irritation or rash occurs: Get medical advice/attention. P341 If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P342+311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.

Additional information

As from 24 August 2023 adequate training is required before industrial or professional use.

2.3 Other hazards

No Information

Results of PBT and vPvB assessment

The product does not meet the criteria for PBT/VPvB in accordance with Annex XIII. Endocrine disrupting properties - Toxicity Name According to EEC CAS-No. No Information Endocrine disrupting properties - Ecotoxicity Name According to EEC CAS-No. No Information

2.1 Classification of the substance or mixture

Classification according to Classification, Labeling & Packaging Regulation (EC) 1272/2008 HAZARD STATEMENTS Other EU extensions EUH204 Skin Irritation, category 2 H315 Skin Sensitizer, category 1 H317 Eye Irritation, category 2 H319 Acute Toxicity, Inhalation, category 4 H332 Respiratory Sensitizer, category 1 H334 STOT, single exposure, category 3, RTI H335 Carcinogenicity, category 2 H351 STOT, repeated exposure, category 2 H373